Dr. Anthony J. Bashall, M.D.
Cardiology (Cardiovascular Disease Physician)
- Medicare participating
At a glance
- Medical school
- Indiana University School of Medicine (2001)
- Years since graduation
- 25
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 808
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2001Medical school: Indiana University School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Cardiovascular Disease Physician primary
IN license 01056994A · SC license 84001
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Indiana University Health Indianapolis, IN
- Franciscan Health Indianapolis Indianapolis, IN
- Franciscan Health Mooresville Mooresville, IN
- Major Hospital Shelbyville, IN
- Decatur County Memorial Hospital Greensburg, IN
Medical groups
- Franciscan Physician Network (1,170 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 808
- Services billed
- 1,394
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 383 | 379 |
| Established patient office or other outpatient visit, 30-39 minutes | 319 | 241 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 198 | 88 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 120 | 76 |
| Established patient office or other outpatient visit, 40-54 minutes | 97 | 79 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 80 | 79 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 74 | 70 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 63 | 63 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 62 | 62 |
| Ultrasound of heart blood flow, valves and chambers | 49 | 49 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 15 companies reported 146 payments worth $60,695 in total to this clinician.
| Compensation for services other than consulting (speaking, faculty) | $55,493 |
|---|---|
| Food and Beverage | $2,664 |
| Travel and Lodging | $2,006 |
| Education | $532 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Novo Nordisk Inc Nov 19, 2025 | Compensation for services other than consulting (speaking, faculty) Wegovy · Obesity | $8,046 |
| Novo Nordisk Inc Mar 4, 2025 | Compensation for services other than consulting (speaking, faculty) Wegovy · Obesity | $7,654 |
| Novo Nordisk Inc Oct 21, 2025 | Compensation for services other than consulting (speaking, faculty) Wegovy · Obesity | $6,084 |
| Novo Nordisk Inc Mar 13, 2025 | Compensation for services other than consulting (speaking, faculty) Wegovy · Obesity | $5,103 |
| Novo Nordisk Inc May 29, 2025 | Compensation for services other than consulting (speaking, faculty) Wegovy · Obesity | $5,103 |
| Novo Nordisk Inc Oct 8, 2025 | Compensation for services other than consulting (speaking, faculty) Wegovy · Obesity | $5,103 |
| Novo Nordisk Inc Apr 16, 2025 | Compensation for services other than consulting (speaking, faculty) Wegovy · Obesity | $5,103 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Jun 17, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · DIABETES | $2,650 |
| Novo Nordisk Inc Jan 1, 2025 | Compensation for services other than consulting (speaking, faculty) Wegovy · Obesity | $2,002 |
| Lilly USA, LLC Feb 24, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · Diabetes | $1,320 |
All 38 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Novo Nordisk Inc Dec 11, 2025 | Education Wegovy · Obesity · in-kind | $32.27 |
| Novo Nordisk Inc Dec 11, 2025 | Education Wegovy · Obesity · in-kind | $32.27 |
| Novo Nordisk Inc Dec 8, 2025 | Education in-kind | $32.27 |
| Novo Nordisk Inc Nov 19, 2025 | Compensation for services other than consulting (speaking, faculty) Wegovy · Obesity | $8,046 |
| Novo Nordisk Inc Nov 19, 2025 | Travel and Lodging Wegovy · Obesity · travel to Columbus, OH · in-kind | $1,106 |
| Lilly USA, LLC Nov 5, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · Diabetes | $880 |
| Novo Nordisk Inc Oct 21, 2025 | Compensation for services other than consulting (speaking, faculty) Wegovy · Obesity | $6,084 |
| Novo Nordisk Inc Oct 21, 2025 | Travel and Lodging Wegovy · Obesity · travel to Greenwood, IN · in-kind | $42.00 |
| Novo Nordisk Inc Oct 8, 2025 | Compensation for services other than consulting (speaking, faculty) Wegovy · Obesity | $5,103 |
| Novo Nordisk Inc Oct 8, 2025 | Travel and Lodging Wegovy · Obesity · travel to Indianapolis, IN · in-kind | $29.40 |
| Lilly USA, LLC Jul 28, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · Diabetes | $880 |
| Novo Nordisk Inc Jul 17, 2025 | Education in-kind | $32.27 |
| Novo Nordisk Inc Jun 25, 2025 | Compensation for services other than consulting (speaking, faculty) Wegovy · Obesity | $1,168 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Jun 17, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · DIABETES | $2,650 |
| Novo Nordisk Inc May 29, 2025 | Compensation for services other than consulting (speaking, faculty) Wegovy · Obesity | $5,103 |
| Novo Nordisk Inc May 29, 2025 | Education Ozempic · Diabetes · in-kind | $32.27 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Apr 18, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · DIABETES | $880 |
| Novo Nordisk Inc Apr 16, 2025 | Compensation for services other than consulting (speaking, faculty) Wegovy · Obesity | $5,103 |
| Novo Nordisk Inc Apr 16, 2025 | Travel and Lodging Wegovy · Obesity · travel to Indianapolis, IN · in-kind | $25.20 |
| Novo Nordisk Inc Apr 15, 2025 | Education Multiple Therapeutic Areas · in-kind | $32.27 |
| Novo Nordisk Inc Apr 11, 2025 | Education Ozempic · Diabetes · in-kind | $32.27 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Apr 9, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · DIABETES | $880 |
| Lilly USA, LLC Mar 19, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · Diabetes | $880 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Mar 14, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · DIABETES | $880 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Mar 14, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · DIABETES | $880 |
| Novo Nordisk Inc Mar 14, 2025 | Education Wegovy · Obesity · in-kind | $32.27 |
| Novo Nordisk Inc Mar 14, 2025 | Education Wegovy · Obesity · in-kind | $32.27 |
| Novo Nordisk Inc Mar 13, 2025 | Compensation for services other than consulting (speaking, faculty) Wegovy · Obesity | $5,103 |
| Actelion Pharmaceuticals US, Inc. Mar 10, 2025 | Education OPSUMIT; UPTRAVI · Cardiology · in-kind | $79.99 |
| Novo Nordisk Inc Mar 4, 2025 | Compensation for services other than consulting (speaking, faculty) Wegovy · Obesity | $7,654 |
| Novo Nordisk Inc Mar 4, 2025 | Travel and Lodging Wegovy · Obesity · travel to Terre Haute, IN · in-kind | $804 |
| Lilly USA, LLC Feb 24, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · Diabetes | $1,320 |
| Novo Nordisk Inc Jan 23, 2025 | Education Wegovy · Obesity · in-kind | $32.27 |
| Novo Nordisk Inc Jan 23, 2025 | Education Wegovy · Obesity · in-kind | $32.27 |
| Novo Nordisk Inc Jan 15, 2025 | Education in-kind | $32.27 |
| Novo Nordisk Inc Jan 2, 2025 | Education Wegovy · Obesity · in-kind | $32.27 |
| Novo Nordisk Inc Jan 2, 2025 | Education in-kind | $32.27 |
| Novo Nordisk Inc Jan 1, 2025 | Compensation for services other than consulting (speaking, faculty) Wegovy · Obesity | $2,002 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.